мÓÆÂÁùºÏ²Ê¿ª½±Ö±²¥

The Lung Ambition Awards is back for its second year with $100,000 to be granted to Canadian research teams working to improve the lives of people with lung cancer. It is a joint partnership between Lung Cancer Canada, the Lung Ambition Alliance and AstraZeneca Canada. All Canadian clinicians and researchers working in the lung cancer space (across the multi-disciplinary spectrum) are encouraged to apply.

Two to three research grants (up to $50,000 CAD each) will be awarded in any of the following three key areas:

• Enhancing early detection – including research into methodologies like screening, incidental pulmonary nodules and blood-based testing, particularly for those individuals not meeting current screening criteria
• Improving the timeliness and/or coordination of care – including ways in which institutions or health care systems can improve care along the patient pathway
• Addressing disparities to improve equity – including identification of systemic barriers and ways to overcome them

Submissions are now open and will close on February 29, 2024.

The review of submissions and selection of winners will be adjudicated solely by Lung Cancer Canada’s Research Committee, and 2–3 winners (maximum award of $50,000 CAD each) will be chosen based on scientific merit, feasibility, and relevance to the Canadian lung cancer community. The Lung Ambition Award winners will be announced in April 2024. Application guidelines and additional details can be found at .

For questions regarding internal procedure, contact the grants facilitator for your faculty. For additional resources, click here for guidance on internal deadlines and submission processes.